aspirin has been researched along with Emergencies in 98 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Emergencies: Situations or conditions requiring immediate intervention to avoid serious adverse results.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A short-cut review was carried out to establish whether the administration of aspirin before computed tomography scanning improved outcome in patients with symptoms suggestive of stroke." | 8.83 | Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. Use of aspirin in acute stroke. ( Body, R; Ferguson, C, 2006) |
| "A short cut review was carried out to establish whether aspirin is a useful adjunct in the treatment of acute pulmonary embolism." | 8.82 | Best evidence topic report. Aspirin in the treatment of acute pulmonary embolism. ( Ferguson, C; Lee, C, 2005) |
| " One hundred two (15%) took aspirin for their chest pain before the arrival of EMS personnel." | 7.70 | Prevalence of aspirin use among patients calling 9-1-1 for chest pain. ( Eisenberg, MS; Jaffy, MB; Meischke, H, 1998) |
| "A short-cut review was carried out to establish whether the administration of aspirin before computed tomography scanning improved outcome in patients with symptoms suggestive of stroke." | 4.83 | Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. Use of aspirin in acute stroke. ( Body, R; Ferguson, C, 2006) |
| "A short cut review was carried out to establish whether aspirin is a useful adjunct in the treatment of acute pulmonary embolism." | 4.82 | Best evidence topic report. Aspirin in the treatment of acute pulmonary embolism. ( Ferguson, C; Lee, C, 2005) |
| "Patients with cardiovascular disease are frequently on aspirin, which may place them at risk for bleeding during surgical procedures." | 3.81 | Utility of VerifyNow for Point-of-Care Identification of an Aspirin Effect Prior to Emergency Cardiac Surgery. ( Dasgupta, A; Nguyen, AN; Wahed, A; Welsh, KJ, 2015) |
| "We present a 19-month-old boy with a history of asthma who presented to the pediatric emergency department with noisy breathing and tachypnea partially responsive to albuterol." | 3.76 | A 19-month-old boy with recurrent respiratory distress. ( Cross, KP; Herr, SM; Randell, KA, 2010) |
| " One hundred two (15%) took aspirin for their chest pain before the arrival of EMS personnel." | 3.70 | Prevalence of aspirin use among patients calling 9-1-1 for chest pain. ( Eisenberg, MS; Jaffy, MB; Meischke, H, 1998) |
| " There were 12 independent significant predictors for readmission: clinical history (a previous history of either congestive heart failure or myocardial infarction, or CABG); acute operation; postoperative complications (time in intensive care unit greater than two days, neurological complications); clinical findings four to seven days after the operation (arrhythmia, systolic murmur equivalent to mitral regurgitation); medication four to seven days after the operation (antidiabetics, diuretics for heart failure, other antiarrhythmics (other than beta blockers, calcium antagonists, and digitalis), and lack of treatment with aspirin)." | 3.69 | Predictors of hospital readmission two years after coronary artery bypass grafting. ( Albertsson, P; Brandrup-Wognsen, G; Emanuelsson, H; Haglid, M; Hartford, M; Herlitz, J; Hjalmarson, A; Karlson, BW; Karlsson, T; Sandén, W, 1997) |
| "An otherwise healthy young man had infectious mononucleosis detected after an atypical clinical onset, including myocarditis and pericarditis." | 2.48 | Myopericarditis during a primary Epstein-Barr virus infection in an otherwise healthy young adult. An unusual and insidious complication. Case report and a 60-year literature review. ( Manfredi, R; Ortolani, P; Sabbatani, S; Trapani, FF; Viale, P, 2012) |
| "Infectious mononucleosis is a common viral illness of adolescence." | 2.48 | Spontaneous splenic rupture in infectious mononucleosis: case report and review of the literature. ( Pomerantz, WJ; Rinderknecht, AS, 2012) |
| "All trials comparing thrombolytic treatment in acute myocardial infarction indicate that either streptokinase, APSAC, or rtPA reduce mortality significantly." | 2.38 | [Myocardial infarct: acute intervention]. ( Bode, C; Katus, HA; Scheffold, T, 1993) |
| "We describe here an incomplete Kawasaki disease occurring in an adult with an unusual manifestation presenting as aseptic purulent meningitis." | 1.33 | [Kawasaki adult disease: case report]. ( Aboutara, M; Belaïda, A; Galempoix, JM; Kaeppler, E; Lanoux, P; Penalba, C, 2006) |
| "Poisonings were considered serious in 9." | 1.31 | [Antipyretic poisoning]. ( Conejo Menor, JL; Lallana Duplá, MT, 2002) |
| " There are doubts in case of emergency operations, especially in transplant patients, concerning dosage and change of medication." | 1.30 | [Preoperative aspirin therapy--a contraindication for kidney transplantation?]. ( Schubert, J; Werner, W, 1997) |
| "Acute myocardial infarctions were registered in group 1 in 25% (11." | 1.29 | [Emergency intracoronary stent implantation: complications and experiences with 124 patients]. ( Arens, R; Heuer, H; Krakau, I; Müller, T; Rissel, U; Schulze-Waltrup, N; Willgeroth, W, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (22.45) | 18.7374 |
| 1990's | 27 (27.55) | 18.2507 |
| 2000's | 29 (29.59) | 29.6817 |
| 2010's | 18 (18.37) | 24.3611 |
| 2020's | 2 (2.04) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, ZZ | 1 |
| Zhang, SZ | 1 |
| Zhou, HM | 1 |
| Fan, YQ | 1 |
| Liu, MH | 1 |
| Zhong, XB | 1 |
| Yang, DY | 1 |
| Guo, Y | 1 |
| Zhuang, XD | 1 |
| Liao, XX | 1 |
| Delvoye, F | 1 |
| Maier, B | 1 |
| Escalard, S | 1 |
| Labreuche, J | 1 |
| Thion, LA | 1 |
| Aknouche, S | 1 |
| Hebert, S | 1 |
| Redjem, H | 1 |
| Smajda, S | 1 |
| Ciccio, G | 1 |
| Allard, J | 1 |
| Sabben, C | 1 |
| Obadia, M | 1 |
| Maertens de Noordhout, A | 1 |
| Olivot, JM | 1 |
| Blanc, R | 1 |
| Piotin, M | 1 |
| Desilles, JP | 1 |
| Mazighi, M | 1 |
| Lin, SY | 1 |
| Huang, HT | 1 |
| Chou, SH | 1 |
| Ho, CJ | 1 |
| Liu, ZM | 1 |
| Chen, CH | 1 |
| Lu, CC | 1 |
| Beynon, C | 1 |
| Scherer, M | 1 |
| Jakobs, M | 1 |
| Jung, C | 1 |
| Sakowitz, OW | 1 |
| Unterberg, AW | 1 |
| Gordon, JL | 1 |
| Fabian, TC | 1 |
| Lee, MD | 1 |
| Dugdale, M | 1 |
| Zhao, W | 1 |
| Mu, Y | 1 |
| Tayama, D | 1 |
| Yeatts, SD | 1 |
| Yogarajah, M | 1 |
| Sivasambu, B | 1 |
| Jaffe, EA | 1 |
| Korsaga-Somé, N | 1 |
| Maruani, A | 1 |
| Abdo, I | 1 |
| Favrais, G | 1 |
| Lorette, G | 1 |
| Stub, D | 1 |
| Smith, K | 1 |
| Bernard, S | 1 |
| Nehme, Z | 1 |
| Stephenson, M | 1 |
| Bray, JE | 1 |
| Cameron, P | 1 |
| Barger, B | 1 |
| Ellims, AH | 1 |
| Taylor, AJ | 1 |
| Meredith, IT | 1 |
| Kaye, DM | 1 |
| Welsh, KJ | 1 |
| Dasgupta, A | 1 |
| Nguyen, AN | 1 |
| Wahed, A | 1 |
| Singletary, EM | 1 |
| Zideman, DA | 1 |
| De Buck, ED | 1 |
| Chang, WT | 1 |
| Jensen, JL | 1 |
| Swain, JM | 1 |
| Woodin, JA | 1 |
| Blanchard, IE | 1 |
| Herrington, RA | 1 |
| Pellegrino, JL | 1 |
| Hood, NA | 1 |
| Lojero-Wheatley, LF | 1 |
| Markenson, DS | 1 |
| Yang, HJ | 1 |
| Assad, M | 1 |
| Coffin-Pichonnet, S | 1 |
| Billotte, C | 1 |
| Denion, É | 1 |
| Nagashima, Z | 1 |
| Tsukahara, K | 1 |
| Uchida, K | 1 |
| Hibi, K | 1 |
| Karube, N | 1 |
| Ebina, T | 1 |
| Imoto, K | 1 |
| Kimura, K | 1 |
| Umemura, S | 1 |
| Mahla, E | 1 |
| Prueller, F | 1 |
| Farzi, S | 1 |
| Pregartner, G | 1 |
| Raggam, RB | 1 |
| Beran, E | 1 |
| Toller, W | 1 |
| Berghold, A | 1 |
| Tantry, US | 1 |
| Gurbel, PA | 1 |
| Oh, JY | 1 |
| Lingaraj, K | 1 |
| Rahmat, R | 1 |
| d'Ythurbide, G | 1 |
| Rousset, P | 1 |
| Carbonne, B | 1 |
| Cabane, J | 1 |
| Fardet, L | 1 |
| Tiev, K | 1 |
| Kettaneh, A | 1 |
| Nguyen, TN | 1 |
| Cross, KP | 1 |
| Randell, KA | 1 |
| Herr, SM | 1 |
| Johansen, M | 1 |
| Afshari, A | 1 |
| Kristensen, BB | 1 |
| Muñiz, AE | 1 |
| Thiele, T | 1 |
| Sümnig, A | 1 |
| Hron, G | 1 |
| Müller, C | 1 |
| Althaus, K | 1 |
| Schroeder, HW | 1 |
| Greinacher, A | 1 |
| Sabbatani, S | 1 |
| Manfredi, R | 1 |
| Ortolani, P | 1 |
| Trapani, FF | 1 |
| Viale, P | 1 |
| Rinderknecht, AS | 1 |
| Pomerantz, WJ | 1 |
| SoRelle, R | 1 |
| Gansera, B | 2 |
| Schmidtler, F | 2 |
| Spiliopoulos, K | 2 |
| Angelis, I | 2 |
| Neumaier-Prauser, P | 2 |
| Kemkes, BM | 2 |
| Manning, BJ | 1 |
| O'Brien, N | 1 |
| Aravindan, S | 1 |
| Cahill, RA | 1 |
| McGreal, G | 1 |
| Redmond, HP | 1 |
| Hwong, TM | 1 |
| Arifi, AA | 1 |
| Wan, IY | 1 |
| Thung, KH | 1 |
| Wan, S | 1 |
| Sung, RY | 1 |
| Yim, AP | 1 |
| Teece, S | 1 |
| Crawford, I | 1 |
| Chu, MW | 1 |
| Wilson, SR | 1 |
| Novick, RJ | 1 |
| Stitt, LW | 1 |
| Quantz, MA | 1 |
| Wazaify, M | 1 |
| Kennedy, S | 1 |
| Hughes, CM | 1 |
| McElnay, JC | 1 |
| Grogan, DM | 1 |
| Lee, C | 1 |
| Ferguson, C | 2 |
| Sakr, M | 1 |
| Wilson, L | 1 |
| Heiss, JM | 1 |
| Haas, DA | 1 |
| Kinduris, S | 1 |
| Vaisvila, T | 1 |
| Petronyte, J | 1 |
| Budrikis, A | 1 |
| Galempoix, JM | 1 |
| Kaeppler, E | 1 |
| Lanoux, P | 1 |
| Belaïda, A | 1 |
| Aboutara, M | 1 |
| Penalba, C | 1 |
| Body, R | 1 |
| Mas, JL | 1 |
| Mégarbane, B | 1 |
| Baud, F | 1 |
| Ducros, A | 1 |
| Matsumoto, M | 1 |
| Suehiro, K | 1 |
| Kubo, Y | 1 |
| Onoue, G | 1 |
| Komatsubara, I | 1 |
| Seito, T | 1 |
| Morimoto, N | 1 |
| Shiraishi, K | 1 |
| Kasai, S | 1 |
| Hagioka, S | 1 |
| Naito, H | 1 |
| Nagae, M | 1 |
| Becker, CE | 1 |
| Hillis, LD | 1 |
| Parry, EH | 1 |
| Knuppel, RA | 1 |
| Rao, PS | 1 |
| Cavanagh, D | 1 |
| Montgomery, RR | 1 |
| Hathaway, WE | 1 |
| Comstock, EG | 1 |
| Boisaubin, EV | 1 |
| Comstock, BS | 1 |
| Faulkner, TP | 1 |
| Carson, SN | 1 |
| Demling, RH | 1 |
| Esquivel, CO | 1 |
| O'Sullivan, J | 1 |
| Schönberger, JP | 1 |
| Bredée, JJ | 1 |
| van Oeveren, W | 1 |
| van Zundert, AA | 1 |
| Verkroost, M | 1 |
| Terwoorst, J | 1 |
| Bavinck, JH | 1 |
| Berreklouw, E | 1 |
| Wildevuur, CR | 1 |
| Himbert, D | 1 |
| Karrillon, GJ | 1 |
| Hvass, U | 1 |
| Juliard, JM | 1 |
| Steg, PG | 1 |
| Aumont, MC | 1 |
| Gourgon, R | 1 |
| Robinson, MH | 1 |
| Wheatley, T | 1 |
| Leach, IH | 1 |
| Rissel, U | 1 |
| Müller, T | 1 |
| Schulze-Waltrup, N | 1 |
| Krakau, I | 1 |
| Arens, R | 1 |
| Willgeroth, W | 1 |
| Heuer, H | 1 |
| Katus, HA | 1 |
| Scheffold, T | 1 |
| Bode, C | 1 |
| Lip, GY | 1 |
| Tean, KN | 1 |
| Dunn, FG | 1 |
| Shibuya, Y | 1 |
| Tanaka, H | 1 |
| Abe, S | 1 |
| Elaxel, CJ | 1 |
| Blach, RK | 1 |
| Hardern, RD | 1 |
| Sharpe, N | 1 |
| Williams, WL | 1 |
| Herlitz, J | 1 |
| Albertsson, P | 1 |
| Brandrup-Wognsen, G | 1 |
| Emanuelsson, H | 1 |
| Haglid, M | 1 |
| Hartford, M | 1 |
| Hjalmarson, A | 1 |
| Karlson, BW | 1 |
| Karlsson, T | 1 |
| Sandén, W | 1 |
| Schuster, S | 1 |
| Koch, A | 1 |
| Burczyk, U | 1 |
| Schiele, R | 1 |
| Wagner, S | 1 |
| Zahn, R | 1 |
| Glunz, HG | 1 |
| Heinrich, F | 1 |
| Stuby, K | 1 |
| Berg, G | 1 |
| Voigtländer, T | 1 |
| Gieseler, U | 1 |
| Jakob, M | 1 |
| Hauptmann, P | 1 |
| Senges, J | 1 |
| Werner, W | 2 |
| Schubert, J | 1 |
| Sloan, VS | 1 |
| Alvarez, JM | 1 |
| Harper, RW | 1 |
| Peverill, RE | 1 |
| Aylward, P | 1 |
| Jaffy, MB | 1 |
| Meischke, H | 1 |
| Eisenberg, MS | 1 |
| Tiffany, BR | 1 |
| Barrali, R | 1 |
| Crowther, SM | 1 |
| Matthews, JG | 1 |
| Epelde, F | 1 |
| Garca-Castrillo Riesgo, L | 1 |
| Loma-Osorio, A | 1 |
| Verdier, J | 1 |
| Recuerda Martnez, E | 1 |
| Terry, P | 1 |
| Davies, M | 1 |
| Loy, M | 1 |
| Hamann, GF | 1 |
| Conejo Menor, JL | 1 |
| Lallana Duplá, MT | 1 |
| Seche, J | 1 |
| de Tornyay, R | 1 |
| Ekert, H | 1 |
| Waters, KD | 1 |
| Poulos, E | 1 |
| Buckingham, JM | 1 |
| Remine, WH | 1 |
| Bulakhova, EK | 1 |
| Agafonova, IA | 1 |
| Zimmerman, J | 1 |
| Arnon, R | 1 |
| Beeri, R | 1 |
| Keret, D | 1 |
| Lysy, J | 1 |
| Ligumski, M | 1 |
| Gonzalez, J | 1 |
| Fich, A | 1 |
| Ackerman, Z | 1 |
| Goldin, E | 1 |
| Puretz, SL | 1 |
| Fleisher, GR | 1 |
| Kearney, TE | 1 |
| Henretig, F | 1 |
| Tenenbein, M | 1 |
| Hancock, EW | 1 |
| Oldroyd, KG | 1 |
| Hornung, RS | 1 |
| Jones, AM | 1 |
| Andrews, NP | 1 |
| Dawes, PT | 1 |
| Carson, PH | 1 |
| Lembo, NJ | 1 |
| Black, AJ | 1 |
| Roubin, GS | 1 |
| Wilentz, JR | 1 |
| Mufson, LH | 1 |
| Douglas, JS | 1 |
| King, SB | 1 |
| White, HD | 1 |
| Gimple, LW | 1 |
| Gold, HK | 1 |
| Leinbach, RC | 1 |
| Coller, BS | 1 |
| Yasuda, T | 1 |
| Johns, JA | 1 |
| Ziskind, AA | 1 |
| Finkelstein, D | 1 |
| Collen, D | 1 |
| Pastorello, E | 1 |
| Qualizza, RM | 1 |
| Luraghi, MT | 1 |
| Ispano, M | 1 |
| Villa, AM | 1 |
| Ortolani, C | 1 |
| Zanussi, C | 1 |
| Terezhalmy, GT | 1 |
| Bowen, LL | 1 |
| Rye, LA | 1 |
| Bhandari, B | 1 |
| Sareen, D | 1 |
| Mandowara, SL | 1 |
| Makhoul, RG | 1 |
| McCann, RL | 1 |
| Austin, EH | 1 |
| Greenberg, CS | 1 |
| Lowe, JE | 1 |
| Wortzman, DJ | 1 |
| Grunfeld, A | 1 |
| Skiendzielewski, JJ | 1 |
| Parrish, G | 1 |
| Harrington, TM | 1 |
| Conte, M | 1 |
| Jarrousse, P | 1 |
| Illingworth, CM | 1 |
| Chua, WH | 1 |
| Choo, JE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Utilization of Thromboelastography to Monitor Rivaroxaban Activity in Trauma and Emergency Surgery Patients[NCT02651909] | 100 participants (Actual) | Observational | 2016-04-30 | Completed | |||
| A Phase IIIB, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Alteplase in Patients With Mild Stroke: Rapidly Improving Symptoms and Minor Neurologic Deficits (PRISMS)[NCT02072226] | Phase 3 | 313 participants (Actual) | Interventional | 2014-05-31 | Terminated (stopped due to The study was terminated due to slow enrollment.) | ||
| A Randomised Controlled Trial of Oxygen Therapy in Acute Myocardial Infarction (AVOID - Air Verses Oxygen In myocarDial Infarction Study)[NCT01272713] | 638 participants (Actual) | Interventional | 2011-10-31 | Active, not recruiting | |||
| Strategy to Avoid Excessive Oxygen in Major Burn Patients (SAVE-O2)[NCT04534972] | Phase 3 | 2,000 participants (Anticipated) | Interventional | 2021-04-15 | Active, not recruiting | ||
| Strategy to Avoid Excessive Oxygen for Critically Ill Trauma Patients (SAVE-O2)[NCT04534959] | Phase 3 | 6,000 participants (Anticipated) | Interventional | 2020-10-15 | Active, not recruiting | ||
| DETermination of the Role of OXygen in Suspected Acute Myocardial Infarction (DETO2X-AMI) Based on the SWEDEHEART Registry[NCT01787110] | Phase 3 | 6,629 participants (Actual) | Interventional | 2013-04-30 | Completed | ||
| Does Platelet Inhibition Predict Surgery Related Bleeding in Patients Undergoing Emergent Cardiac Surgery During Dual Antiplatelet Therapy - a Pilot Study[NCT01468597] | 167 participants (Actual) | Observational | 2011-01-31 | Completed | |||
| A Prospective, Nonrandomized, Study Comparing the Use of Aspirin and Intraoperative Blood Loss and Postoperative Complications Following Open Inguinal Hernia Repair.[NCT02084615] | 300 participants (Anticipated) | Interventional | 2014-08-31 | Enrolling by invitation | |||
| Maintenance Of aNtiplatElet Therapy in Patients With Coronary Stenting Undergoing Surgery[NCT03445273] | 1,800 participants (Anticipated) | Observational [Patient Registry] | 2018-11-21 | Not yet recruiting | |||
| Atrial Fibrillation Registry at the Emergency Department of the Medical University of Vienna: A Tool for Structured Diagnosis and Treatment[NCT03272620] | 3,000 participants (Anticipated) | Observational [Patient Registry] | 2014-10-22 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Reported here is the percentage of participants who died due to any cause during the study. (NCT02072226)
Timeframe: From baseline to Day 90
| Intervention | percentage of participants (Number) |
|---|---|
| Alteplase + Aspirin Placebo | 0.6 |
| Alteplase Placebo + Aspirin | 0 |
Reported here is the percentage of participants who died due to stroke and neurological disorders. (NCT02072226)
Timeframe: From baseline to Day 90
| Intervention | percentage of participants (Number) |
|---|---|
| Alteplase + Aspirin Placebo | 0 |
| Alteplase Placebo + Aspirin | 0 |
mRS score was determined by the investigator. The mRS is a 7 point scale (0-6) with 0: No symptoms at all, 1: No significant disability despite symptoms, able to carry out all usual duties and activities, 2: Slight disability, unable to carry out all previous activities but able to look after own affairs without assistance, 3: Moderate disability requiring some help, but able to walk without assistance, 4: Moderately severe disability, unable to walk without assistance and unable to attend to own bodily needs without assistance, 5: Severe disability, bedridden, incontinent and requiring constant nursing care and attention, 6: death prior to Day 90. Reported is the percentage of participants with scores of 0 or 1 on the mRS. (NCT02072226)
Timeframe: Day 90
| Intervention | percentage of participants (Number) |
|---|---|
| Alteplase + Aspirin Placebo | 78.2 |
| Alteplase Placebo + Aspirin | 81.5 |
An adverse event is any untoward medical occurrence in a subject administered a pharmaceutical product and which does not necessarily have to have a causal relationship with the treatment. An adverse event can therefore be any unfavorable and unintended sign (including an abnormal laboratory finding, for example), symptom, or disease temporally associated with the use of a pharmaceutical product, whether or not considered related to the pharmaceutical product. Preexisting conditions which worsen during a study are also considered as adverse events. (NCT02072226)
Timeframe: From baseline up to Day 90: Non-serious adverse events were collected through the Day 30 visit. Serious adverse events were collected through the end of study at Day 90.
| Intervention | percentage of participants (Number) |
|---|---|
| Alteplase + Aspirin Placebo | 77.3 |
| Alteplase Placebo + Aspirin | 68.0 |
A serious adverse event (SAE) was defined as any experience that suggested a significant hazard, contraindication, side effect, or precaution, and fulfilled any of the following criteria: fatal (resulted in death), life-threatening, required in-patient hospitalization or prolongation of existing hospitalization, resulted in persistent or significant disability/incapacity, was a congenital anomaly/birth defect, was medically significant or required intervention to prevent any of the other outcomes listed here. (NCT02072226)
Timeframe: From baseline to Day 90
| Intervention | percentage of participants (Number) |
|---|---|
| Alteplase + Aspirin Placebo | 26.0 |
| Alteplase Placebo + Aspirin | 13.1 |
ICH was considered symptomatic if it was not seen on computed tomography (CT) or magnetic resonance imaging (MRI) scan at baseline and any neurologic decline was attributed to it by the local investigator. To detect intracranial hemorrhage, neuroimaging (CT or MRI) scan was performed at 22 to 36 hours after study drug administration. (NCT02072226)
Timeframe: Within 36 hours after study drug administration on Day 1
| Intervention | percentage of participants (Number) |
|---|---|
| Alteplase + Aspirin Placebo | 3.2 |
| Alteplase Placebo + Aspirin | 0 |
mRS score was determined by the investigator. The mRS is a 7 point scale (0-6) with 0: No symptoms at all, 1: No significant disability despite symptoms, able to carry out all usual duties and activities, 2: Slight disability, unable to carry out all previous activities but able to look after own affairs without assistance, 3: Moderate disability requiring some help, but able to walk without assistance, 4: Moderately severe disability, unable to walk without assistance and unable to attend to own bodily needs without assistance, 5: Severe disability, bedridden, incontinent and requiring constant nursing care and attention, 6: death before Day 90. Reported are the percentages of participants for all scores on the mRS. (NCT02072226)
Timeframe: Day 90
| Intervention | percentage of participants (Number) | |||||
|---|---|---|---|---|---|---|
| mRS at Day 90 - 0 | mRS at Day 90 - 1 | mRS at Day 90 - 2 | mRS at Day 90 - 3 | mRS at Day 90 - 4 | mRS at Day 90 - 5 or 6 (death) | |
| Alteplase + Aspirin Placebo | 44.9 | 33.3 | 11.5 | 2.6 | 5.1 | 2.6 |
| Alteplase Placebo + Aspirin | 50.3 | 31.2 | 11.5 | 3.2 | 2.5 | 1.3 |
To detect ICH, neuroimaging (CT or MRI) scan was performed at 22 to 36 hours after study drug administration. (NCT02072226)
Timeframe: Within 36 hours after study drug administration on Day 1
| Intervention | percentage of participants (Number) | |
|---|---|---|
| Any ICH within 36 hours reported by site | Any ICH within 36 hours reported by central reader | |
| Alteplase + Aspirin Placebo | 7.1 | 7.1 |
| Alteplase Placebo + Aspirin | 2.6 | 3.3 |
Global favorable recovery is an integrated assessment of participants who meet the following: mRS Score 0-1, National Institutes of Health Stroke Scale (NIHSS) Score 0-1, Barthel Index [BI] greater than or equal to 95, and Glasgow Outcome Scale [GOS] equal to 1. mRS Score 0-1: 0= No symptoms at all, 1= No significant disability despite symptoms, able to carry out all usual duties and activities. NIHSS Score 0-1: 0= No stroke symptoms and 1= Minor stroke symptoms. BI is a 10 question index with a total score range of 0-100 with 100 being the best outcome. GOS =1: Good recovery. Reported here are the percentages of participants who achieved a favorable score on each of these scales. (NCT02072226)
Timeframe: Day 90
| Intervention | percentage of participants (Number) | |||
|---|---|---|---|---|
| mRS 0 - 1 at Day 90 | NIHSS 0 - 1 at Day 90 | BI >= 95 at Day 90 | GOS = 1 at Day 90 | |
| Alteplase + Aspirin Placebo | 78.2 | 85.0 | 79.3 | 81.5 |
| Alteplase Placebo + Aspirin | 81.5 | 81.7 | 88.7 | 85.6 |
Intracranial bleed within 48 hours, Reoperation after closure of sternotomy for the purpose of controlling bleeding, Transfusion of equal to or more than 5 Units of packed red blood cells within a 48-hour period, Chest tube output of equal to or more than 2 L within a 24-h period. (NCT01468597)
Timeframe: until postoperative day 2
| Intervention | participants (Number) |
|---|---|
| One Group | 72 |
(NCT01468597)
Timeframe: until postoperative day 5
| Intervention | milliters (Median) |
|---|---|
| One Group | 1996 |
20 reviews available for aspirin and Emergencies
| Article | Year |
|---|---|
A systematic review of guidelines for dual antiplatelet therapy in coronary artery bypass graft.
Topics: Aspirin; Coronary Artery Bypass; Coronary Artery Disease; Deprescriptions; Dual Anti-Platelet Therap | 2021 |
Anticoagulant and antiplatelet medications encountered in emergency surgery patients: a review of reversal strategies.
Topics: Anticoagulants; Aspirin; Benzimidazoles; Clopidogrel; Dabigatran; Emergencies; Enoxaparin; Fondapari | 2013 |
Part 9: First Aid: 2015 International Consensus on First Aid Science With Treatment Recommendations.
Topics: Airway Management; Aspirin; Asthma; Cardiopulmonary Resuscitation; Chest Pain; Emergencies; Emergenc | 2015 |
[Discontinuation of treatment with platelet aggregation inhibitors in surgical patients with cardiac stents].
Topics: Angioplasty, Balloon, Coronary; Aspirin; Blood Loss, Surgical; Clopidogrel; Coronary Thrombosis; Dru | 2010 |
Myopericarditis during a primary Epstein-Barr virus infection in an otherwise healthy young adult. An unusual and insidious complication. Case report and a 60-year literature review.
Topics: Amoxicillin; Antibodies, Viral; Aspirin; Diagnostic Errors; Drug Eruptions; Electrocardiography; Eme | 2012 |
Spontaneous splenic rupture in infectious mononucleosis: case report and review of the literature.
Topics: Abdominal Pain; Adolescent; Air Ambulances; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; | 2012 |
Best evidence topic report. Gastric lavage in aspirin and non-steroidal anti-inflammatory drug overdose.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Charcoal; Drug Interactions; Drug Overdose; Emerge | 2004 |
Best evidence topic report. Aspirin in the treatment of acute pulmonary embolism.
Topics: Acute Disease; Aspirin; Emergencies; Evidence-Based Medicine; Humans; Platelet Aggregation Inhibitor | 2005 |
Best evidence topic report. Aspirin and the risk of intracranial complications following head injury.
Topics: Aspirin; Cerebral Hemorrhage; Craniocerebral Trauma; Emergencies; Evidence-Based Medicine; Humans; P | 2005 |
Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. Use of aspirin in acute stroke.
Topics: Aged; Aspirin; Emergencies; Evidence-Based Medicine; Humans; Male; Platelet Aggregation Inhibitors; | 2006 |
[Acute poisoning: general management and main causes].
Topics: Acute Disease; Adrenergic beta-Antagonists; Adult; Alcoholic Intoxication; Amphetamines; Analgesics; | 2006 |
[Acute and chronic headaches].
Topics: Acetaminophen; Adult; Aged; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Aspir | 2006 |
Percutaneous transluminal coronary angioplasty.
Topics: Angina, Unstable; Angioplasty, Balloon; Animals; Aspirin; Calcium Channel Blockers; Coronary Artery | 1984 |
Nonsteroidal antiinflammatory drug-induced colonic stricture. An unusual cause of large bowel obstruction and perforation.
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colon; Colonic Diseases; Delayed-Ac | 1995 |
[Myocardial infarct: acute intervention].
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cardiovascular Agents; Combined Modality Therapy; Eme | 1993 |
[Emergency drug therapy of pulmonary thromboembolism].
Topics: Anticoagulants; Aspirin; Emergencies; Heparin; Humans; Plasminogen Activators; Platelet Aggregation | 1995 |
Advances in the pharmacology of acute coronary syndrome. Platelet inhibition.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clinical Trials as Topic; Combined Modality Therapy; Corona | 2000 |
Acute myocardial infarction: a true medical emergency.
Topics: Aspirin; Clinical Trials as Topic; Drug Therapy, Combination; Emergencies; Evaluation Studies as Top | 1989 |
Pharmacotherapeutics in urgent dental care.
Topics: Aminophenols; Anesthetics, Local; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anxiety; Aspirin; | 1986 |
Aspirin poisoning.
Topics: Aspirin; Child; Emergencies; Humans; Reye Syndrome; Risk Factors | 1986 |
4 trials available for aspirin and Emergencies
| Article | Year |
|---|---|
Air Versus Oxygen in ST-Segment-Elevation Myocardial Infarction.
Topics: Aged; Air; Ambulances; Aspirin; Biomarkers; Chest Pain; Combined Modality Therapy; Coronary Circulat | 2015 |
Air Versus Oxygen in ST-Segment-Elevation Myocardial Infarction.
Topics: Aged; Air; Ambulances; Aspirin; Biomarkers; Chest Pain; Combined Modality Therapy; Coronary Circulat | 2015 |
Air Versus Oxygen in ST-Segment-Elevation Myocardial Infarction.
Topics: Aged; Air; Ambulances; Aspirin; Biomarkers; Chest Pain; Combined Modality Therapy; Coronary Circulat | 2015 |
Air Versus Oxygen in ST-Segment-Elevation Myocardial Infarction.
Topics: Aged; Air; Ambulances; Aspirin; Biomarkers; Chest Pain; Combined Modality Therapy; Coronary Circulat | 2015 |
Air Versus Oxygen in ST-Segment-Elevation Myocardial Infarction.
Topics: Aged; Air; Ambulances; Aspirin; Biomarkers; Chest Pain; Combined Modality Therapy; Coronary Circulat | 2015 |
Air Versus Oxygen in ST-Segment-Elevation Myocardial Infarction.
Topics: Aged; Air; Ambulances; Aspirin; Biomarkers; Chest Pain; Combined Modality Therapy; Coronary Circulat | 2015 |
Air Versus Oxygen in ST-Segment-Elevation Myocardial Infarction.
Topics: Aged; Air; Ambulances; Aspirin; Biomarkers; Chest Pain; Combined Modality Therapy; Coronary Circulat | 2015 |
Air Versus Oxygen in ST-Segment-Elevation Myocardial Infarction.
Topics: Aged; Air; Ambulances; Aspirin; Biomarkers; Chest Pain; Combined Modality Therapy; Coronary Circulat | 2015 |
Air Versus Oxygen in ST-Segment-Elevation Myocardial Infarction.
Topics: Aged; Air; Ambulances; Aspirin; Biomarkers; Chest Pain; Combined Modality Therapy; Coronary Circulat | 2015 |
Air Versus Oxygen in ST-Segment-Elevation Myocardial Infarction.
Topics: Aged; Air; Ambulances; Aspirin; Biomarkers; Chest Pain; Combined Modality Therapy; Coronary Circulat | 2015 |
Air Versus Oxygen in ST-Segment-Elevation Myocardial Infarction.
Topics: Aged; Air; Ambulances; Aspirin; Biomarkers; Chest Pain; Combined Modality Therapy; Coronary Circulat | 2015 |
Air Versus Oxygen in ST-Segment-Elevation Myocardial Infarction.
Topics: Aged; Air; Ambulances; Aspirin; Biomarkers; Chest Pain; Combined Modality Therapy; Coronary Circulat | 2015 |
Air Versus Oxygen in ST-Segment-Elevation Myocardial Infarction.
Topics: Aged; Air; Ambulances; Aspirin; Biomarkers; Chest Pain; Combined Modality Therapy; Coronary Circulat | 2015 |
Air Versus Oxygen in ST-Segment-Elevation Myocardial Infarction.
Topics: Aged; Air; Ambulances; Aspirin; Biomarkers; Chest Pain; Combined Modality Therapy; Coronary Circulat | 2015 |
Air Versus Oxygen in ST-Segment-Elevation Myocardial Infarction.
Topics: Aged; Air; Ambulances; Aspirin; Biomarkers; Chest Pain; Combined Modality Therapy; Coronary Circulat | 2015 |
Air Versus Oxygen in ST-Segment-Elevation Myocardial Infarction.
Topics: Aged; Air; Ambulances; Aspirin; Biomarkers; Chest Pain; Combined Modality Therapy; Coronary Circulat | 2015 |
[The use of acetylsalicylic acid in patients with ischemic cardiomyopathy cared for in Spanish emergency services (results of the EVICURE Study). Evaluacion del Manejo de la cardiopatia isquemica en los Servicios de Urgencias Hospitalarios of the Sociedad
Topics: Aspirin; Chi-Square Distribution; Emergencies; Emergency Service, Hospital; Fibrinolytic Agents; Fir | 2000 |
Effect of pretreatment with aspirin versus aspirin plus dipyridamole on frequency and type of acute complications of percutaneous transluminal coronary angioplasty.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Coronary Artery Bypass; Dipyridamole; Drug Therapy, Combina | 1990 |
Acute myocardial infarction: a true medical emergency.
Topics: Aspirin; Clinical Trials as Topic; Drug Therapy, Combination; Emergencies; Evaluation Studies as Top | 1989 |
75 other studies available for aspirin and Emergencies
| Article | Year |
|---|---|
Antiplatelet Therapy During Emergent Extracranial Internal Carotid Artery Stenting: Comparison of Three Intravenous Antiplatelet Perioperative Strategies.
Topics: Abciximab; Adenosine Monophosphate; Administration, Intravenous; Aged; Aspirin; Carotid Artery, Inte | 2021 |
The Safety of Continuing Antiplatelet Medication Among Elderly Patients Undergoing Urgent Hip Fracture Surgery.
Topics: Aged; Aged, 80 and over; Aspirin; Blood Loss, Surgical; Blood Transfusion; Dipyridamole; Drug Therap | 2019 |
Initial experiences with Multiplate® for rapid assessment of antiplatelet agent activity in neurosurgical emergencies.
Topics: Adenosine Diphosphate; Aged; Aged, 80 and over; Arachidonic Acid; Aspirin; Clopidogrel; Embolization | 2013 |
Comparison of statistical and operational properties of subject randomization procedures for large multicenter clinical trial treating medical emergencies.
Topics: Algorithms; Aspirin; Computer Simulation; Double-Blind Method; Emergencies; Fibrinolytic Agents; Hum | 2015 |
Spontaneous iliopsoas haematoma: a complication of hypertensive urgency.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Transfusion; Diabetes Mellitus, Type 2 | 2015 |
[Kasabach-Merritt phenomenon (KMP) exacerbated by platelet transfusions].
Topics: Aspirin; Axilla; Combined Modality Therapy; Compression Bandages; Disease Progression; Disseminated | 2015 |
Utility of VerifyNow for Point-of-Care Identification of an Aspirin Effect Prior to Emergency Cardiac Surgery.
Topics: Aspirin; Cardiovascular Diseases; Emergencies; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male | 2015 |
[Acute unilateral arteritic anterior ischemic optic neuropathy becoming bilateral despite corticosteroid therapy].
Topics: Acute Disease; Aged; Alzheimer Disease; Anti-Inflammatory Agents; Anticoagulants; Aspirin; Disease P | 2016 |
Impact of preoperative dual antiplatelet therapy on bleeding complications in patients with acute coronary syndromes who undergo urgent coronary artery bypass grafting.
Topics: Acute Coronary Syndrome; Aged; Aspirin; Blood Transfusion; Clopidogrel; Coronary Angiography; Corona | 2017 |
Does Platelet Reactivity Predict Bleeding in Patients Needing Urgent Coronary Artery Bypass Grafting During Dual Antiplatelet Therapy?
Topics: Aged; Aspirin; Blood Loss, Surgical; Coronary Artery Bypass; Drug Therapy, Combination; Emergencies; | 2016 |
Spontaneous spinal epidural haematoma associated with aspirin intake.
Topics: Anticoagulants; Aspirin; Emergencies; Hematoma, Epidural, Spinal; Humans; Male; Middle Aged | 2008 |
[Liver infarcts with early HELLP syndrome and probable catastrophic antiphospholipid syndrome].
Topics: Adrenal Cortex Hormones; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Co | 2009 |
Aspirin-induced postoperative bleeding.
Topics: Aspirin; Emergencies; Humans; Male; Middle Aged; Nursing Assessment; Platelet Aggregation Inhibitors | 2009 |
A 19-month-old boy with recurrent respiratory distress.
Topics: Acid-Base Equilibrium; Albuterol; Alkalosis, Respiratory; Aspirin; Asthma; Bicarbonates; Bites, Huma | 2010 |
Thrombolytic therapy for acute stroke in a teenager.
Topics: Adolescent; Aspirin; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Cerebral Angiography; Defibril | 2012 |
Platelet transfusion for reversal of dual antiplatelet therapy in patients requiring urgent surgery: a pilot study.
Topics: Aged; Aged, 80 and over; Aspirin; Blood Loss, Surgical; Clopidogrel; Drug Administration Schedule; D | 2012 |
Need for emergency CABG decreases, but morbidity and mortality remain high.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Coronary Artery Bypass; Emergencies; Homocysteine; Humans; | 2002 |
Urgent or emergent coronary revascularization using bilateral internal thoracic artery after previous clopidogrel antiplatelet therapy.
Topics: Aged; Aged, 80 and over; Aspirin; Blood Transfusion; Chest Tubes; Clopidogrel; Coronary Artery Bypas | 2003 |
The effect of aspirin on blood loss and transfusion requirements in patients with femoral neck fractures.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Loss, Surgical; Blo | 2004 |
Rupture of a giant coronary artery aneurysm due to Kawasaki disease.
Topics: Anticoagulants; Aspirin; Cardiac Tamponade; Child, Preschool; Combined Modality Therapy; Coronary An | 2004 |
[Urgent or emergent coronary revascularization using bilateral internal thoracic artery after previous clopidogrel antiplatelet therapy].
Topics: Aged; Aspirin; Blood Transfusion; Clopidogrel; Coronary Artery Bypass; Data Interpretation, Statisti | 2004 |
Does clopidogrel increase blood loss following coronary artery bypass surgery?
Topics: Aged; Aspirin; Blood Loss, Surgical; Blood Transfusion; Clopidogrel; Coronary Artery Bypass; Critica | 2004 |
Prevalence of over-the-counter drug-related overdoses at Accident and Emergency departments in Northern Ireland--a retrospective evaluation.
Topics: Acetaminophen; Age Factors; Alcohol Drinking; Aspirin; Data Collection; Databases as Topic; Drug Com | 2005 |
The pharmacology of recommended medical emergency drugs.
Topics: Adrenal Cortex Hormones; American Dental Association; Ammonia; Anticonvulsants; Aspirin; Bronchodila | 2004 |
[Emergency measures in acute arterial occlusion. Why there are still colleagues who do it incorrectly?].
Topics: Acute Disease; Angiography; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Embolism; Emergencies | 2006 |
Management of medical emergencies in the dental office: conditions in each country, the extent of treatment by the dentist.
Topics: Adrenal Cortex Hormones; Albuterol; Analgesics, Opioid; Anti-Allergic Agents; Anticonvulsants; Aspir | 2006 |
[Bleeding after cardiac surgery: risk factors, frequency, and outcomes].
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Cardiac Surgical Procedures; Diabetes Mellitus, | 2006 |
[Kawasaki adult disease: case report].
Topics: Adult; Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Emergencies; Humans; Lysine; M | 2006 |
[Treating ischemic stroke as an emergency to prevent cerebral infarction or limit its spread].
Topics: Aspirin; Cerebral Infarction; Emergencies; Fibrinolytic Agents; Humans; Ischemic Attack, Transient; | 2006 |
[Coronary artery bypass grafting for simultaneous subacute stent thrombosis after sirolimus-eluting stent implantation].
Topics: Aged, 80 and over; Angina Pectoris; Aspirin; Coronary Artery Bypass; Coronary Restenosis; Coronary T | 2008 |
The alcoholic patient as a toxic emergency.
Topics: 1-Propanol; Acidosis; Alcoholic Intoxication; Alcoholism; Aspirin; Blood Glucose; Diagnosis, Differe | 1984 |
Management of rheumatic heart disease in tropical countries.
Topics: Adolescent; Adult; Aspirin; Child; Child, Preschool; Costs and Cost Analysis; Digoxin; Diuretics; Em | 1983 |
Septic shock in obstetrics.
Topics: Animals; Anti-Bacterial Agents; Aspirin; Disseminated Intravascular Coagulation; Dopamine; Emergenci | 1984 |
Acute bleeding emergencies.
Topics: Acute Disease; Aspirin; Blood Coagulation Disorders; Blood Platelet Disorders; Blood Vessels; Child; | 1980 |
Assessment of the efficacy of activated charcoal following gastric lavage in acute drug emergencies.
Topics: Absorption; Adult; Aspirin; Barbiturates; Charcoal; Drug Evaluation; Emergencies; Gastric Lavage; Hu | 1982 |
Aspirin failure in symptomatic atherosclerotic carotid artery disease.
Topics: Aged; Aspirin; Carotid Artery Diseases; Emergencies; Endarterectomy; Humans; Intracranial Arterioscl | 1981 |
Acute myocardial infarction.
Topics: Anistreplase; Aspirin; Emergencies; Family Practice; Humans; Myocardial Infarction | 1995 |
Preoperative therapy of low-dose aspirin in internal mammary artery bypass operations with and without low-dose aprotinin.
Topics: Aprotinin; Aspirin; Blood Component Transfusion; Blood Loss, Surgical; Drug Therapy, Combination; Em | 1993 |
[Incidence and prognosis of early primary cardiogenic shock in myocardial infarction].
Topics: Aged; Aged, 80 and over; Angioplasty; Aspirin; Emergencies; Female; Heparin; Humans; Male; Middle Ag | 1994 |
[Emergency intracoronary stent implantation: complications and experiences with 124 patients].
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Aspirin; Blood Coagulation Tests; Co | 1994 |
Treatment of atrial fibrillation in a district general hospital.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Digoxin; Echocardiography; Electric Co | 1994 |
Aspirin is a hazard for vitreoretinal surgery.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Contraindications; Emergencies; Humans; Intr | 1996 |
Aspirin and suspected myocardial infarction: a life-saving treatment we too often forget.
Topics: Aspirin; Drug Utilization; Emergencies; Humans; Myocardial Infarction; Practice Patterns, Physicians | 1995 |
Medical management after myocardial infarction: an evidence-based perspective.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Clinical Trials as T | 1996 |
Thrombolysis after acute myocardial infarction: are Canadian physicians up to the challenge?
Topics: Aspirin; Canada; Coronary Thrombosis; Emergencies; Humans; Myocardial Infarction; Myocardial Reperfu | 1997 |
Predictors of hospital readmission two years after coronary artery bypass grafting.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Anti-Arrhythmia Agents; Aspirin; Coronary Artery | 1997 |
[Early treatment of acute myocardial infarct: implementation of therapy guidelines in routine clinical practice, MITRA pilot phase].
Topics: Adrenergic beta-Antagonists; Aged; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inh | 1997 |
[Preoperative aspirin therapy--a contraindication for kidney transplantation?].
Topics: Aspirin; Blood Coagulation Tests; Contraindications; Dose-Response Relationship, Drug; Elective Surg | 1997 |
[Stroke. Earliest possible acute intervention and promising successful secondary prevention. "Newest trends in epidemiology, pathogenesis and therapy of stroke". Symposium in Dresden, 4 October 1997].
Topics: Aspirin; Cerebrovascular Disorders; Emergencies; Humans; Platelet Aggregation Inhibitors; Secondary | 1997 |
Aspirin in in-flight emergencies.
Topics: Aerospace Medicine; Aircraft; Aspirin; Emergencies; Heart Diseases; Humans; Travel | 1998 |
Emergency coronary artery bypass grafting (CABG) after failed coronary artery intervention--caution regarding the combined use of aspirin, ticlopidine and abciximab.
Topics: Abciximab; Adult; Angina Pectoris; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; | 1998 |
Glycoprotein IIb/IIIa inhibitors, surgery and bleeding.
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Blood Loss, Surgical; Co | 1998 |
Prevalence of aspirin use among patients calling 9-1-1 for chest pain.
Topics: Acute Disease; Adult; Aged; Aspirin; Chest Pain; Cross-Sectional Studies; Drug Utilization; Emergenc | 1998 |
Aspirin-related small bowel diaphragm disease identified during emergency laparotomy.
Topics: Aged; Aspirin; Emergencies; Humans; Intestinal Perforation; Jejunal Diseases; Laparotomy; Male | 2000 |
Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Timing of aspirin administration in acute myocardial infarction.
Topics: Aspirin; Drug Administration Schedule; Electrocardiography; Emergencies; Emergency Service, Hospital | 2001 |
[Emergencies in general practice, 16: Transitory ischemic attacks. When suspected ASS and heparin are contraindicated!].
Topics: Aspirin; Contraindications; Diagnosis, Differential; Emergencies; Family Practice; Heparin; Humans; | 2001 |
[Antipyretic poisoning].
Topics: Acetaminophen; Adolescent; Age Factors; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Ster | 2002 |
Experiences in clinical problem solving. Nursing decisions. Emergency care of an aspirin overdose patient.
Topics: Aspirin; Emergencies; Humans; Male; Middle Aged; Nursing Assessment; Nursing Care; Patient Care Plan | 1978 |
Hematologic emergencies in children.
Topics: Acute Disease; Acute Kidney Injury; Adolescent; Anemia, Aplastic; Anemia, Hemolytic, Autoimmune; Asp | 1978 |
The emergency cold leg.
Topics: Aspirin; Dextrans; Embolism; Emergencies; Femoral Artery; Heparin; Humans; Ischemia; Leg; Methods; P | 1975 |
Results of emergency surgical management of hemorrhagic duodenal ulcer.
Topics: Adolescent; Adult; Aged; Aspirin; Duodenal Ulcer; Emergencies; Female; Gastrectomy; Gastroscopy; Hum | 1975 |
[Wissler's subsepsis allergica as a manifestation of drug allergy].
Topics: Adult; Aspirin; Diagnosis, Differential; Diphenhydramine; Dipyrone; Drug Hypersensitivity; Emergenci | 1992 |
Seasonal fluctuations in acute upper gastrointestinal bleeding: lack of effect of nonsteroidal anti-inflammatory drugs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Duodenal Ulcer; Emergencies; Esophagitis; Gastriti | 1992 |
First-aid supplies for backpacking.
Topics: Aspirin; Attitude to Health; Emergencies; First Aid; Humans; Sports; Sunscreening Agents; Walking | 1992 |
Gastric decontamination in the poisoned patient.
Topics: Acetaminophen; Adolescent; Aspirin; Charcoal; Child, Preschool; Emergencies; Female; Gastric Lavage; | 1991 |
A possible acute MI: what location and type?
Topics: Aspirin; Coronary Angiography; Coronary Disease; Drug Therapy, Combination; Electrocardiography; Eme | 1991 |
Spontaneous haemarthrosis following thrombolytic therapy for myocardial infarction.
Topics: Aged; Aspirin; Emergencies; Female; Hemarthrosis; Humans; Male; Middle Aged; Myocardial Infarction; | 1990 |
Correlation between template bleeding times and spontaneous bleeding during treatment of acute myocardial infarction with recombinant tissue-type plasminogen activator.
Topics: Adenosine Diphosphate; Aspirin; Bleeding Time; Emergencies; Fibrin Fibrinogen Degradation Products; | 1989 |
[Occurrence of drug reactions].
Topics: Acetaminophen; Adult; Anaphylaxis; Angioedema; Aspirin; Asthma; Drug Hypersensitivity; Emergencies; | 1986 |
Management of patients with heparin-associated thrombocytopenia and thrombosis requiring cardiac surgery.
Topics: Adult; Aged; Aspirin; Cardiopulmonary Bypass; Coronary Artery Bypass; Dipyridamole; Emergencies; Fem | 1987 |
Delayed absorption following enteric-coated aspirin overdose.
Topics: Adult; Aspirin; Emergencies; Humans; Intestinal Absorption; Male; Tablets, Enteric-Coated; Time Fact | 1987 |
Mental confusion in an elderly, chronically ill patient.
Topics: Aged; Aspirin; Chronic Disease; Cognition Disorders; Confusion; Emergencies; Female; Humans; Renal D | 1986 |
[The fate of 165 hemorrhagic ulcers treated in a special intensive care unit].
Topics: Adrenal Cortex Hormones; Aged; Anti-Inflammatory Agents; Anticoagulants; Aspirin; Emergencies; Esoph | 1973 |
Childhood poisonings. Who is to blame?
Topics: Accidents, Home; Age Factors; Alcoholic Intoxication; Antidepressive Agents; Aspirin; Child; Child B | 1974 |
Mortality following emergency partial gastrectomy for gastro-duodenal haemorrhage.
Topics: Age Factors; Aged; Aspirin; Blood Transfusion; Emergencies; Female; Gastrectomy; Gastrointestinal He | 1971 |